6.17
Nextcure Inc Aktie (NXTC) Neueste Nachrichten
Is NextCure Inc. a good long term investmentGame-changing returns - PrintWeekIndia
NXTC Stock: Exploring Nextcure Inc’s Growth - investchronicle.com
What drives NextCure Inc. stock priceConsistent double returns - PrintWeekIndia
NextCure stock soars after positive data for bone disease treatment - Investing.com Australia
NextCure Soars On Encouraging Preclinical Data Of Brittle Bone Disease Drug Candidate - Nasdaq
NextCure Inc. Stock Analysis and ForecastPhenomenal returns - Autocar Professional
Nextcure Stock Skyrockets Nearly 45% In After-Hours Trading After Sharing Preclinical Data For Brittle Bone Disease - 富途牛牛
What analysts say about NextCure Inc. stockSuperior return velocity - PrintWeekIndia
NextCure Stock Soars After-Hours On Promising Preclinical Data For Rare Bone Disease Treatment - MSN
How NextCure Inc. stock performs during market volatilityRisk Adjusted Stock Signals - Newser
NextCure, Inc. Presents Promising Preclinical Data for NC605 in Osteogenesis Imperfecta at Brittle Bone Society Meeting - Nasdaq
Preclinical Data Demonstrate Anti-Siglec-15 Treatment Improves Bone Microarchitecture and Reduces Fracture Incidence in Mice with Moderate-to-Severe Osteogenesis Imperfecta - The Manila Times
What makes NextCure Inc. stock price move sharplyConsistent Growth Alert - Newser
Why NextCure Inc. stock attracts strong analyst attentionFree Access to Community - Newser
Piper Sandler lowers NextCure stock price target to $15 after reverse split By Investing.com - Investing.com South Africa
Piper Sandler lowers NextCure stock price target to $15 after reverse split - Investing.com India
NextCure initiates one-for-twelve reverse stock split on Nasdaq By Investing.com - Investing.com Nigeria
NextCure Implements Reverse Stock Split on Nasdaq - TipRanks
NextCure initiates one-for-twelve reverse stock split on Nasdaq - Investing.com
NextCure Announces One-for-Twelve Reverse Stock Split - TipRanks
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):